BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1157 related articles for article (PubMed ID: 30480761)

  • 1. Mefloquine for preventing malaria in pregnant women.
    González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011444. PubMed ID: 30480761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mefloquine for preventing malaria in pregnant women.
    González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment.
    Radeva-Petrova D; Kayentao K; ter Kuile FO; Sinclair D; Garner P
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD000169. PubMed ID: 25300703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent preventive treatment for malaria in infants.
    Esu EB; Oringanje C; Meremikwu MM
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD011525. PubMed ID: 34273901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial.
    González R; Desai M; Macete E; Ouma P; Kakolwa MA; Abdulla S; Aponte JJ; Bulo H; Kabanywanyi AM; Katana A; Maculuve S; Mayor A; Nhacolo A; Otieno K; Pahlavan G; Rupérez M; Sevene E; Slutsker L; Vala A; Williamsom J; Menéndez C
    PLoS Med; 2014 Sep; 11(9):e1001735. PubMed ID: 25247995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent preventive treatment for malaria in infants.
    Esu EB; Oringanje C; Meremikwu MM
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011525. PubMed ID: 31792925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mefloquine for preventing malaria during travel to endemic areas.
    Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy.
    Sicuri E; Fernandes S; Macete E; González R; Mombo-Ngoma G; Massougbodgi A; Abdulla S; Kuwawenaruwa A; Katana A; Desai M; Cot M; Ramharter M; Kremsner P; Slustker L; Aponte J; Hanson K; Menéndez C
    PLoS One; 2015; 10(4):e0125072. PubMed ID: 25915616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women.
    Mathanga DP; Uthman OA; Chinkhumba J
    Cochrane Database Syst Rev; 2011 Oct; 2011(10):CD006689. PubMed ID: 21975756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
    Pryce J; Hine P
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD006404. PubMed ID: 30620055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
    Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M
    J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial.
    González R; Nhampossa T; Mombo-Ngoma G; Mischlinger J; Esen M; Tchouatieu AM; Mendes A; Figueroa-Romero A; Zoleko-Manego R; Lell B; Lagler H; Stoeger L; Dimessa LB; El Gaaloul M; Sanz S; Méndez S; Piqueras M; Sevene E; Ramharter M; Saúte F; Menendez C;
    Lancet Infect Dis; 2024 May; 24(5):476-487. PubMed ID: 38224706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi.
    Kapito-Tembo A; Meshnick SR; van Hensbroek MB; Phiri K; Fitzgerald M; Mwapasa V
    J Infect Dis; 2011 Feb; 203(4):464-72. PubMed ID: 21216867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.
    Capan-Melser M; Mombo Ngoma G; Akerey-Diop D; Basra A; Würbel H; Groger M; Mackanga JR; Zoleko-Manego R; Schipulle U; Schwing J; Lötsch F; Rehman K; Matsiegui PB; Agnandji ST; Adegnika AA; Bélard S; González R; Kremsner PG; Menendez C; Ramharter M
    J Antimicrob Chemother; 2015; 70(6):1898-902. PubMed ID: 25722300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review.
    ter Kuile FO; van Eijk AM; Filler SJ
    JAMA; 2007 Jun; 297(23):2603-16. PubMed ID: 17579229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial.
    González R; Mombo-Ngoma G; Ouédraogo S; Kakolwa MA; Abdulla S; Accrombessi M; Aponte JJ; Akerey-Diop D; Basra A; Briand V; Capan M; Cot M; Kabanywanyi AM; Kleine C; Kremsner PG; Macete E; Mackanga JR; Massougbodgi A; Mayor A; Nhacolo A; Pahlavan G; Ramharter M; Rupérez M; Sevene E; Vala A; Zoleko-Manego R; Menéndez C
    PLoS Med; 2014 Sep; 11(9):e1001733. PubMed ID: 25247709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria.
    Zani B; Gathu M; Donegan S; Olliaro PL; Sinclair D
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD010927. PubMed ID: 24443033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin-based combination therapy for treating uncomplicated malaria.
    Sinclair D; Zani B; Donegan S; Olliaro P; Garner P
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007483. PubMed ID: 19588433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.
    Graves PM; Choi L; Gelband H; Garner P
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008152. PubMed ID: 29393511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.